πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
12,558
Companies
407
Drugs tracked
2,719

Quick answer

NovaPharmaNews tracks 12,558 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

Showing page 46 of 524 Β· Phase 3 first, then by program name

  1. MORE and MI and NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Polysubstance Abuse

    phase 3 other active

    1 trial

  2. MOVIPREP

    Takeda Pharmaceuticals International AG

    Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.

    phase 3 small molecule completed

    1 trial

  3. MP-424

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatitis C

    phase 3 small molecule completed

    2 trials

  4. MP-424

    Vertex Pharmaceuticals (Ireland) Limited

    Chronic Hepatitis C

    phase 3 small molecule completed

    1 trial

  5. MPs

    China SXT Pharmaceuticals

    Hematological Diseases

    phase 3 mab active

    1 trial

  6. MRI

    United Therapeutics Europe Ltd

    Prostate Neoplasm

    phase 3 other completed

    1 trial

  7. MTX

    China SXT Pharmaceuticals

    Gestational Trophoblastic Tumor

    phase 3 small molecule active

    1 trial

  8. MYOBLOC

    SUPERNUS PHARMACEUTICALS, INC.

    Sialorrhea

    phase 3 small molecule completed

    2 trials

  9. MYOBLOC Low Dose

    SUPERNUS PHARMACEUTICALS, INC.

    Sialorrhea

    phase 3 small molecule terminated

    1 trial

  10. Magnesium Pantoprazole

    Takeda Pharmaceuticals International AG

    GERD

    phase 3 small molecule completed

    1 trial

  11. Magnesium Pantoprazole 20 mg

    Takeda Pharmaceuticals International AG

    Gastric pH Control

    phase 3 small molecule terminated

    1 trial

  12. Maralixibat

    Mirum Pharmaceuticals International B.V.

    Progressive Familial Intrahepatic Cholestasis (PFIC)

    phase 3 small molecule terminated

    3 trials

  13. Maralixibat

    Mirum Pharmaceuticals International B.V.

    Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)

    phase 3 small molecule active

    1 trial

  14. Maribavir

    Takeda Pharmaceuticals International AG

    Cytomegalovirus (CMV)

    phase 3 small molecule active

    6 trials

  15. Marijuana Check-Ins

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 3 other completed

    1 trial

  16. MarzAA

    CATALYST PHARMACEUTICALS, INC.

    Hemophilia A With Inhibitor

    phase 3 mab terminated

    1 trial

  17. Matching Placebo

    IRONWOOD PHARMACEUTICALS INC

    Chronic Constipation

    phase 3 small molecule completed

    1 trial

  18. Mavorixafor

    X4 Pharmaceuticals, Inc

    WHIM Syndrome

    phase 3 small molecule active

    1 trial

  19. Mavorixafor

    X4 Pharmaceuticals, Inc

    Neutropenia

    phase 3 small molecule active

    2 trials

  20. Medium-dosage COVID-19 Vaccine,Inactivated

    SINOVAC BIOTECH LTD

    COVID-19

    phase 3 mab terminated

    1 trial

  21. Medpulser Electroporation with Bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Head Neck Cancer

    phase 3 other terminated

    1 trial

  22. Medtronic Talent Stent-Graft-System

    Rhythm Pharmaceuticals Netherlands B.V.

    Aortic Diseases

    phase 3 other completed

    1 trial

  23. Megestrol（YiningοΌ‰

    First Tracks Biotherapeutics

    Stage III Esophageal Squamous Cell Carcinoma

    phase 3 small molecule completed

    1 trial

  24. Mesenchymal Stromal Cells

    China SXT Pharmaceuticals

    Chronic Graft-Versus-Host Disease

    phase 3 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 12,558 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources